Iranian attacks on nine U.S. locations across the Middle East in the two weeks since the cease-fire broke down show that the country maintains an ability to inflict damage on precise targets, despite the Trump administration’s repeated claims that Iran’s military capabilities have been diminished or destroyed.
A New York Times visual analysis of U.S. military bases and other sites found the strikes have caused damage to living quarters and working areas, drone shelters, radar systems and other structures.
One of the attacks, on Muwaffaq Salti Air Base in Jordan, killed three U.S. soldiers and wounded others. A military official told The Times that nearly a dozen troops were also wounded severely enough by Iranian missile and drone attacks in Jordan and other countries this month that they were flown to a U.S. military hospital in Germany for treatment.
President Donald Trump’s net approval rating has hit its lowest level ever, according to a new poll.
The survey, conducted by the American Research Group between July 16 and 20, revealed that a total of 30 percent of Americans approved of Trump’s handling of his job as president, while 67 percent disapproved. This gave Trump a net approval rating of -37 percent, his lowest rating yet.
Behaving erratically and coming off unhinged, Chump has earned a reputation. Kathrine Frich (DAGENS) reports:
[. . .]
Venezuela’s state-owned oil and gas company, known as PDVSA, has not published oil revenue figures since 2016, and the Trump administration has not publicly disclosed the exact figures it controls. It is also unclear who within the administration oversees those funds. Trump said he would control the revenue when he announced the first fifty-million-barrel tranche on social media just days after Maduro’s ouster. However, Executive Order 14373, which establishes Foreign Government Deposit Funds as property of the Venezuelan government held in custody by the Treasury Department, indicates that the secretary of state will give the Treasury instructions for disbursements.
Except for a few details shared with Congress and in Executive Order 14373, the Trump administration has provided almost no information on the system it has established to sell Venezuelan oil, collect the revenue, and use the funds. The administration has also not released the written agreements it has entered into with the Venezuelan government, traders, buyers, banks, and other entities involved in the process. Both Rubio and Treasury Secretary Scott Bessent separately committed to Congress to share a copy of the written agreements governing U.S. control of Venezuelan oil exports, though it is unclear whether those copies were delivered to Congress, and no copies have been made public.
Despite Rubio’s insistence before Congress that commodities trading companies Trafigura and Vitol were a “short-term fix” to quickly sell the first tranche of oil, both companies—each of which has a history of bribery schemes related to oil sales—remain involved in Venezuela five months later. A third trader, GE Warren, has since entered the picture, and the Trump administration has offered no explanation for their ongoing role. In mid-April, the State Department witness told Congress that accounting firm KPMG would conduct quarterly audits of how Venezuelan oil revenues are being spent, to include a retrospective audit “from the beginning,” but said he did not know when the reports would be available.
***WATCH: Senator Murray’s full opening remarks***
Washington, D.C. — Today, at a Senate Veterans’ Affairs Committee (SVAC) hearing on the future of Department of Veterans Affairs (VA) research—U.S. Senator Patty Murray (D-WA), a former chair and senior member of SVAC, delivered the following opening remarks.
Senator Murray’s remarks, as delivered, are below:
“Look, I think Senators on both sides of this aisle have a real appreciation of VA’s research enterprise, which has been at the forefront of cutting-edge science for more than 100 years, it’s led to breakthroughs like the pacemaker, the first successful liver transplant, the nicotine patch, and CT scanning.
“But I am not sure that the Trump administration has that same appreciation. And I am very concerned the actions by this administration have demoralized VA research staff, and have created instability in research funding, and put up barriers that has slowed the research process.
“On the very first day of the Trump Administration, all VA research staff became subject to a hiring freeze and probationary firings. As a result – research at the Pittsburgh VA to predict stroke risk was put on hold, enrollment into clinical trials for advanced cancer was delayed, and a clinical trial in Florida on preventing dementia and heart disease was cancelled.
“And look, Mr. Chairman, I could go on. I have heard a lot of stories like that.
“The Department also enforced vacancy cuts and staffing caps on its facilities. Though these cuts technically exclude research staff, a study at a VA site in the Pacific Northwest was delayed because staffing caps prevented them from hiring nurses who were needed to administer that study.
“These workforce actions have also taken a toll on employees at VA’s Central Office responsible for getting new research studies up and running.
“VA researchers now report startup times for their studies often stretch to more than a year. Those delays are partially due to a wildly inefficient hiring process for VA research staff. Researchers are reporting to us that the time to hire a new member of their staff now often takes up to six months. As a result, a planned study on RSV missed its enrollment window and could not even enroll participants. Another clinical trial closed after it took six months to hire a researcher. The study’s principal investigator and its lead clinician both resigned from the VA after this debacle.
“VA researchers are not only being undermined by delays and cuts at the Department, but also by instability and cuts at other federal agencies like the National Institutes of Health, which frequently provides funding for our VA researchers. For example, a VA researcher’s NIH grant for studying opioid use disorder among minority veterans was cancelled—why? Because it was deemed ‘DEI-related.’
“Large VA research sites are also reporting their non-VA federal funding is down one-third or more compared to the previous year.
“And in one final blow to research, the Office of Management and Budget published a proposed rule that would require all federal grants, including those for VA research, to be approved by political appointees. That doesn’t make sense—let the political appointees overrule the scientist on what research is worth pursuing and funding.
“Given the current state of VA research under this administration – there is a demoralized workforce with limited access to non-VA federal funding – so it is really inexplicable to request a decrease in funding for VA research for fiscal year 2027.
“I am speaking here in place of Senator Blumenthal, but I can tell you right now as Vice Chair of Appropriations it is my intention to rip up Trump’s budget up and write a new one.
“I really hope our VA witnesses will take the concerns raised in this hearing seriously and commit to taking action to address them. If VA wants to ensure it can recruit and retain the brightest minds to conduct research and provide clinical care for our nation’s heroes, it has to work to restore the trust it has lost with many of its research staff.
“This committee and this congress should stand up for research. And it should stand up for science. And it should stand up for veterans—that’s where I am, Mr. Chairman.”
###